1,515 results on '"Alexander, G. Caleb"'
Search Results
52. Health information technology and physicians' knowledge of drug costs.
53. Effect of Direct-to-Consumer Advertising on Statin Use in the United States
54. Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
55. Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case–control study
56. Patterns of Manufacturer Coupon Use for Prescription Drugs in the US, 2017-2019
57. Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis
58. Inappropriate Fentanyl Prescribing Among Nursing Home Residents in the United States
59. Elderly Patients' Preferences and Experiences with Providers in Managing Their Drug Costs
60. General Pediatricians' Views on Allocating More Time in Primary Care Practice to Children with Special Health Care: Results from a National Survey
61. General Pediatricians' Views on Allocating More Time in Primary Care Practice to Children with Special Health Care: Results from a National Survey
62. Prescribing cascades in ambulatory care: A structured synthesis of evidence.
63. Potential drug–drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross‐sectional study of the National Covid Cohort Collaborative (N3C).
64. Single and combined use of fall-risk-increasing drugs and fracture risk:A population-based case–control study
65. Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C
66. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews
67. Prescription drug monitoring programs: Assessing the association between 'best practices' and opioid use in Medicare
68. Estimated Use of Prescription Medications Among Individuals Incarcerated in Jails and State Prisons in the US
69. Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis
70. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising
71. The comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation
72. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation
73. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis
74. Effect of a “pill mill” law on opioid prescribing and utilization: The case of Texas
75. Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006–2009
76. Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective
77. National Trends in Ambulatory Oral Anticoagulant Use
78. Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder
79. Opioid Oversupply After Joint and Spine Surgery: A Prospective Cohort Study
80. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
81. Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018-2021)
82. Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic
83. Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
84. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
85. Distribution of Abatement Funds Arising From US Opioid Litigation
86. Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study
87. Pharmacologic Treatment of Type 2 Diabetes in the United States, Sweden, and Israel
88. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
89. Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease
90. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin : population based cohort study
91. Risk of gastrointestinal bleeding associated with oral anticoagulants : population based retrospective cohort study
92. Construct Validity and Factor Structure of Survey-based Assessment of Cost-related Medication Burden
93. Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products
94. Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel
95. Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM–Coded Data Among Older Adults
96. Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
97. Correlates of nonmedical use of stimulants and methamphetamine use in a national sample
98. Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members
99. Mind the Gap: Understanding the Effects of Pharmaceutical Direct-to-Consumer Advertising
100. Reducing Branded Prescription Drug Prices: A Review of Policy Options
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.